Indication

Drug Effect

50 clinical trials

61 products

10 drugs

Product
ORIN1001
Product
ADC189
Product
Placebo
Product
Psilocybin
Product
Enoxaparin
Product
Insulin
Product
IE
Product
Buspirone
Product
Lacosamide
Product
Ibuprofen
Product
Melatonin
Clinical trial
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
Status: Active (not recruiting), Estimated PCD: 2023-10-06
Clinical trial
Marcaine Post-Operative Pain Study
Status: Completed, Estimated PCD: 2022-12-01
Product
Cytotec
Product
Transamine
Product
PSORI-CM01
Product
Torasemide
Clinical trial
PFA 100 Evaluation and Reference Interval HOACNY
Status: Not yet recruiting, Estimated PCD: 2024-01-01
Product
Aspirin
Clinical trial
Cannabidiol and Vascular Reactivity to Skin Sensory Nerve Stimulation
Status: , Estimated PCD: 2025-12-31
Product
Alfentanil
Product
Dextrose
Product
Herombopag
Product
MB07133
Product
Midazolam
Product
Morphine
Product
Rifaximin
Clinical trial
The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
Status: Completed, Estimated PCD: 2022-09-16
Product
THC
Product
Cinacalcet
Product
Esketamine
Product
Propofol
Drug
T-VEC
Product
Mirabegron
Clinical trial
How Distress Alters Opioid Drug Effects and Abuse Liability
Status: Completed, Estimated PCD: 2022-04-28
Product
Oxycodone
Product
Thiopental
Product
Captopril